A Clinical Study to Evaluate the Safety of MF1, a New Treatment for Parkinson's Disease-related Disorders (MF1 Study)

NCT07666022 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

Healthy Adult Male
PARKINSON DISEASE (Disorder)

Interventions

DRUG: MF-1
DRUG: Placebo

Sponsor

University of Shizuoka

Collaborators

[object Object]